United Therapeutics Corp. (UTHR)
541.70
-29.68
(-5.19%)
USD |
NASDAQ |
Oct 02, 16:00
537.12
-4.58
(-0.85%)
After-Hours: 20:00
United Therapeutics Profit Margin (Quarterly) : 42.51% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 42.51% |
| March 31, 2026 | 35.18% |
| December 31, 2025 | 46.10% |
| September 30, 2025 | 42.36% |
| June 30, 2025 | 38.76% |
| March 31, 2025 | 40.56% |
| December 31, 2024 | 40.94% |
| September 30, 2024 | 41.27% |
| June 30, 2024 | 38.90% |
| March 31, 2024 | 45.24% |
| December 31, 2023 | 35.32% |
| September 30, 2023 | 43.91% |
| June 30, 2023 | 43.45% |
| March 31, 2023 | 47.52% |
| December 31, 2022 | 26.88% |
| September 30, 2022 | 46.38% |
| June 30, 2022 | 24.84% |
| March 31, 2022 | 51.94% |
| December 31, 2021 | 27.02% |
| September 30, 2021 | 36.59% |
| June 30, 2021 | 38.66% |
| March 31, 2021 | 7.46% |
| December 31, 2020 | 25.67% |
| September 30, 2020 | 45.04% |
| June 30, 2020 | 29.59% |
| Date | Value |
|---|---|
| March 31, 2020 | 38.65% |
| December 31, 2019 | 16.91% |
| September 30, 2019 | 32.98% |
| June 30, 2019 | 54.90% |
| March 31, 2019 | -136.4% |
| December 31, 2018 | 17.12% |
| September 30, 2018 | 25.81% |
| June 30, 2018 | 38.90% |
| March 31, 2018 | 62.82% |
| December 31, 2017 | 4.09% |
| September 30, 2017 | 62.02% |
| June 30, 2017 | -12.60% |
| March 31, 2017 | 48.21% |
| December 31, 2016 | 26.97% |
| September 30, 2016 | 39.64% |
| June 30, 2016 | 49.95% |
| March 31, 2016 | 63.82% |
| December 31, 2015 | 25.85% |
| September 30, 2015 | |
| June 30, 2015 | 28.58% |
| March 31, 2015 | -5.08% |
| December 31, 2014 | 33.47% |
| September 30, 2014 | -7.65% |
| June 30, 2014 | 34.65% |
| March 31, 2014 | 47.52% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Liquidia Corp. | 43.52% |
| MannKind Corp. | -17.40% |
| Insmed, Inc. | -3.11% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.77% |
| Return on Assets | 17.64% |
| Return on Invested Capital | 19.77% |
| Gross Profit Margin (Quarterly) | 87.30% |
| Operating Margin (Quarterly) | 42.23% |
| Return on Net Operating Assets | 56.78% |